IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)

Overview of attention for article published in Pediatric Rheumatology, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 62 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 1 news story.

Targeting IL-6 Succeeds in Systemic JIA

MedPage Today, 06 Apr 2018

Action Points Interleukin (IL)-6 blockade using tocilizumab (Actemra) can be an effective treatment for systemic juvenile…